United States · FDA National Drug Code directory
Metopirone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76336-455_47d0c075-05db-df45-e063-6294a90a4e12
- Product NDC
- 76336-455
- Form
- CAPSULE, GELATIN COATED
- Composition / generic term
- Metyrapone
- Labeler
- HRA Pharma Rare Diseases
- Marketing category
- NDA
- Marketing start / end (source format)
- 19620125
- Source listing expiry
- 20271231
Source-listed ingredients
- METYRAPONE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 18 CAPSULE, GELATIN COATED in 1 BOTTLE (76336-455-18) · 76336-455-18
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →